TSE:6971
TSE:6971Electronic

Assessing Kyocera (TSE:6971) Valuation After Belharra Sustainable Industrial Printer Rollout

Kyocera (TSE:6971) is in focus after a board meeting on January 22, 2026, to review the succession of its chemical business, following the global rollout of its environmentally focused Belharra industrial inkjet photo printer. See our latest analysis for Kyocera. The recent board meeting on the chemical business succession comes shortly after the Belharra rollout. Kyocera’s 30 day share price return of 7.08% and 1 year total shareholder return of 47.46% point to firm, sustained momentum...
TSE:8031
TSE:8031Trade Distributors

Is It Too Late To Consider Mitsui (TSE:8031) After Its Strong Multi Year Rally?

If you are wondering whether Mitsui's current share price fairly reflects the business, you are not alone. This article will walk you through what the numbers are really saying about value. Mitsui's share price recently closed at ¥5,133, with returns of 11.6% over 30 days, 8.0% year to date, 73.3% over 1 year, 188.4% over 3 years and a very large gain over 5 years. That naturally raises questions about how much potential or risk is already priced in. Recent coverage has focused on Mitsui's...
TSE:3064
TSE:3064Trade Distributors

December’s Sales Surge Might Change The Case For Investing In MonotaRO (TSE:3064)

MonotaRO Co., Ltd. reported non-consolidated sales of ¥31,390 million for December 2025, up from ¥24,159 million in the same month a year earlier. This sharp year-on-year increase in monthly sales highlights strong demand for MonotaRO’s products and suggests meaningful momentum in its core operations. Against this backdrop of robust December sales growth, we’ll examine how the latest results shape MonotaRO’s broader investment narrative and appeal. AI is about to change healthcare. These 109...
TSE:3407
TSE:3407Chemicals

Assessing Asahi Kasei’s Valuation After New LifeVest Launch And Healthcare Momentum

Why the new LifeVest launch matters for Asahi Kasei (TSE:3407) Asahi Kasei’s subsidiary ZOLL Medical has rolled out its next generation LifeVest wearable cardioverter defibrillator across the U.S., sharpening the group’s focus on Critical Care and drawing fresh attention to its Healthcare business. See our latest analysis for Asahi Kasei. Asahi Kasei’s recent healthcare updates are landing at a time when momentum in the shares has picked up, with a 30 day share price return of 9.08% and a 90...